Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
76 0% |
 |
Gilead SciencesGILD |
54 1.8% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Mar 2025 | 69 | |
| Feb 2025 | 74 | |
| Jan 2025 | 69 | |
| Dec 2024 | 66 |
How do employees feel about the future at Intra-Cellular Therapies?
The Business Outlook at Intra-Cellular Therapies is positive according to its employees. The average outlook rating 69 (out of 100) is high.
Analyzing Business Outlook, how is Intra-Cellular Therapies performing compared to its industry peers?
Intra-Cellular Therapies overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 69th percentile.
How has the business outlook at Intra-Cellular Therapies changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at Intra-Cellular Therapies.
Why is it important to track the business outlook at Intra-Cellular Therapies?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Intra-Cellular Therapies.
